Stability indicating HPLC method for the simultaneous determination of moxifloxacin and prednisolone in pharmaceutical formulations

Table 7 Assay results of moxifloxacin and prednisolone in commercial eye drops

Products	Ingredient	Label value (mg per mL)	% Recovery ±RSD (%)
Eye drops	Ingredient	Label value (mg per mL)	% Recovery ±RSD (%)
Occumox P	Moxifloxacin	5	100.3 ± 0.3
Occumox P	Prednisolone	10	99.0 ± 0.7
Moftrex P	Moxifloxacin	5	100.7 ± 0.1
	Prednisolone	10	98.9 ±0.7

n = Average of 10 determinations, Chromatographic conditions: mobile phase Methanol: 18 mM phosphate buffer 62:38, v/v, pH 2.8, Column BDS Hypersil C8 (250 X 4.6, 5 μm), flow rate 1.5 mL min^-1, injection volume 20 μL, wavelength 254 nm.

ISSN: 2661-801X